Texas Yale Capital Corp. trimmed its holdings in Clorox Co (NYSE:CLX) by 48.9% during the second quarter, Holdings Channel reports. The institutional investor owned 13,582 shares of the company’s stock after selling 12,988 shares during the quarter. Texas Yale Capital Corp.’s holdings in Clorox were worth $2,080,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Janus Henderson Group PLC lifted its position in shares of Clorox by 28.4% during the first quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock valued at $284,204,000 after purchasing an additional 391,569 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Clorox by 21.5% during the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after purchasing an additional 335,835 shares in the last quarter. Martingale Asset Management L P lifted its position in shares of Clorox by 152.4% during the first quarter. Martingale Asset Management L P now owns 211,703 shares of the company’s stock valued at $33,971,000 after purchasing an additional 127,816 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Clorox by 65.4% during the first quarter. PNC Financial Services Group Inc. now owns 299,966 shares of the company’s stock valued at $48,133,000 after purchasing an additional 118,660 shares in the last quarter. Finally, California Public Employees Retirement System lifted its position in shares of Clorox by 15.0% during the first quarter. California Public Employees Retirement System now owns 805,832 shares of the company’s stock valued at $129,304,000 after purchasing an additional 104,896 shares in the last quarter. 76.83% of the stock is currently owned by hedge funds and other institutional investors.
CLX has been the topic of a number of recent analyst reports. UBS Group raised their price target on shares of Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a research report on Friday. Royal Bank of Canada raised their price target on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a research report on Friday. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target on the stock in a research report on Monday, July 29th. Bank of America reissued a “neutral” rating and set a $154.00 price target (down from $165.00) on shares of Clorox in a research report on Thursday, May 2nd. Finally, Wells Fargo & Co reissued a “hold” rating and set a $153.00 price target on shares of Clorox in a research report on Thursday. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $154.07.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The company’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.66 earnings per share. As a group, sell-side analysts forecast that Clorox Co will post 6.4 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be given a $1.06 dividend. This is a positive change from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date of this dividend is Tuesday, July 30th. This represents a $4.24 annualized dividend and a yield of 2.72%. Clorox’s payout ratio is currently 67.09%.
In other Clorox news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $157.61, for a total value of $3,215,086.39. Following the sale, the senior vice president now owns 4,896 shares of the company’s stock, valued at $771,658.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.40% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.